Home -> Law Blog Directory -> Intellectual Property Law Blogs -> IPKat
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Intellectual Property Law
: IPKatInvalidating a patent after expiry of the patent term? German Federal Court of Justice confirms broad standing to sue
By Johanna Gibson, David Pearce, Jeremy Phillips and Ilanah Simon.
![]() |
The Federal Court of Justice disagreed and declared that the lawsuit for invalidity should have been examined on the merits for all patent claims. Eventually, it invalidated claims 1-20 in their entirety, but ruled that claim 21 (as well as the claims dependent on claim 21) is valid as limited by KPN during the proceedings.
The Federal Court of Justice emphasized at the outset that the bar of legal interest in a lawsuit for patent invalidity should not be set high. Suing for patent invalidity provides a defense to a person having a reason to fear that it will be sued for present or past infringement, whether or not the infringement lawsuit is based on a patent that has already expired. Standing to sue for invalidity is denied only where there is no longer any "reasonable possibility of being sued for infringement".
A pending patent infringement action creates a legal interest for the opposing party file a countersuit for invalidity of all claims of the same patent, irrespective of which specific claims are asserted in the infringement action. Standing to sue could be denied with regard to individual patent claims only if the attacked embodiment "evidently" does not infringe that specific claim, neither directly nor under the doctrine of equivalents.
In the present case, claim 1 (which is not alleged to having been infringed) relates to a method that can typically be performed by using a device protected under claim 21 (which is the claim alleged to be infringed). Hence, the alleged infringer has reason to fear that it may be sued for infringement of claim 1 at some point later as well. The alleged infringer has an interest in invalidating claim 1 and thus has standing to sue.
The Federal Court of Justice added that if the patentee had formally waived asserting claim 1, the infringement defendant's standing to sue for invalidity of claim 1 could have been questioned. However, the patentee had not made any such waiver.

Comment

The Federal Court of Justice corrects this view by recalling that, under German law, the bar for standing to sue for patent invalidity is low. This principle should not depend upon whether the patent has expired or not.
There are two side aspects of the case that are also worth mentioning. First, the patentee could have prevented the invalidation of claim 1 (and the claims dependent on claim 1) by a declaration that it would not assert claim 1 against the other party. That could have preserved the independent method claim (that could have been used later against other infringers).
Second, the Federal Court of Justice emphasizes that the two independent claims in the disputed patent were related, in the sense that the device of claim 21 was "typically adapted to perform the method protected under claim 1". The Court does not formally declare that this is a condition of bringing an invalidity action. Still, it underscores that this fact is sufficient for a "reasonable fear" that the patentee will assert both independent claims against the alleged infringer, and thus sufficient to establish standing to sue for invalidity.
Importantly, the Federal Court of Justice does not argue that this condition is always met whenever a patent contains several independent claims. Nonetheless, when a European patent relates to several inventions, these must be "so linked as to form a single general inventive concept" (Art. 82 EPC). Therefore, cases in which an infringement lawsuit based on one independent claim will not create a "reasonable fear" of an infringement lawsuit under a different independent claim, will be rare.
Full post as published by IPKat on October 19, 2020 (boomark / email).
Anna Nicole Smith's Legal Troubles
Court cases and legal issues related to Anna Nicole Smith
Selection of State Supreme Court Judges
How State Court Judges are Selected
Law Enforcement and Criminal Justice Career Choices
Descriptions of law enforcement occupations
Privacy Protection Act 42 USC 21A
Federal Newsroom Law
California Supreme Court Proposition 8 Decision
Court Rejects Challenges to Proposition 8, but Finds Marriages Valid
Federal Adoption Tax Credit
Financial Incentive for Adoptive Parents
Zantac Patent
GlaxoSmithKline and Cypress Pharmaceutical settle patent infringement dispute.
Soliris Patent
Alexion Pharmaceuticals Inc. agrees to pay the Oklahoma Medical Research Foundation a $10 million patent infringement settlement.
DRAM Patent
ProMOS Technologies and Mosel Vitelic pay MOSAID Technologies an undisclosed patent infringement settlement.
Sony
to Pay $18.5 Million For Patent Infringment
Qualcomm Settles Patent Suit for $891 Million
The Princeton Review
$2.6 million settlement reached in patent infringement case.










